Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Cheaper Nevirapine as Effective in Treating HIV Among African Woman as Lopinavir | |
|
| |
An international study appearing in the journal PLoS Medicine reveals that nevirapine is as effective in treating AIDS among African women as more expensive drugs such as lopinavir/ritonavir and can be safely used as an affordable treatment option.
This finding is important as it confirms the recommendations from the World Health Organization that an increasingly common nevirapine-based treatment regimen is an affordable and effective option for the initial treatment of HIV in resource-limited settings.
The clinical trial involved 500 HIV-infected African women who had not previously taken antiretroviral treatment in seven countries (Botswana, Kenya, Malawi, South Africa, Uganda, Zambia, and Zimbabwe). The researchers, led by Shahin Lockman from the Harvard School of Public Health, randomized half of the women to receive antiretroviral therapy containing nevirapine and half to receive antiretroviral therapy containing lopinavir/ritonavir, a more expensive combination.
The researchers found that a similar number of women died in each group and each combination was as effective at controlling the level of HIV virus. In addition, similar proportions of women in both treatment groups developed serious drug-related signs and symptoms and laboratory abnormalities.
However, whereas 14% of the women in the nevirapine group stopped treatment because of adverse effects, none of the women in the lopinavir/ritonavir group stopped treatment. Furthermore, women in the nevirapine group developed more drug resistance than women in the lopinavir/ritonavir group.
The authors say: "These data support the WHO recommendation of [nevirapine-based treatment] as an initial affordable and effective HIV treatment regimen in resource limited settings, and provide reassurance regarding the efficacy of this regimen. However, these results also underscore the importance of early toxicity monitoring with nevirapine-based regimens."
They continue: "Our findings suggest that nevirapine, with careful early toxicity monitoring, remains an acceptable choice for first-line antiretroviral therapy in resource limited settings, until better tolerated and potentially more efficacious regimens become accessible."
The authors add: "Treatment failure observed in both arms also highlights the importance of access to effective second treatment options, as well as consideration of other effective, better-tolerated first-line regimens."
Source-Eurekalert
| |
|
|
More News on: Oral Health And AIDS, AIDS/HIV, AIDS/HIV - Epidemiology, AIDS/HIV - Clinical Features, AIDS/HIV - Health Education, AIDS/HIV - Prevention And Transmission, AIDS / HIV - Treatment, AIDS/HIV- Lab Tests and Faqs, Prostitution: Fresh Stakes in the Oldest Trade, HIV Symptom
 Comment & Contribute
|
Related Links
AIDS and Pregnancy
The Acquired immune deficiency syndrome is brought about by the deadly human immunodeficiency virus. In the USA alone an estimate of 120,000 - ...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical ...
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for ...
AIDS/HIV Related News
AIDS Cure may be Possible for Some, Say Scientists
Top AIDS scientists have said a cure for AIDS might not work for all people but might be able to cure some patients. The experts have ...
Imphal Observes International AIDS Candle Light Memorial Day and Generates Awareness
In memory of AIDS victims, Imphal observed the 30th International AIDS Candle Light Memorial Day. This special day is observed across ...
Latest Setback Sheds Light on 'Gap' for HIV Vaccine Efforts
The failure of the most recent efficacy trial for HIV vaccine has delivered yet another setback to 26 years of efforts. With the next ...
Russia Lacks a Strategy to Combat AIDS
Due to the lack of any government strategy to fight AIDS in Russia, the number of deaths due to this disease is rapidly increasing, a senior ...
Over 180,000 Teenagers Living With HIV in Nigeria, Says UNICEF
The United Nation Children Education Fund (UNICEF) said that more than 180,000 teenagers are living with HIV in Nigeria. The ...
Agency Says AIDS-related Deaths Falling in S. Africa
AIDS-related deaths are falling as ramped-up treatment begins to have an impact, says agency. After years of dragging its heels ...
Medwonders Health Network
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
HIV
Complete Medindia Resources
|
| News Categories: |
| » | Targeting Cell ‘Power Plants’ Promising Approach for Prevention of Drug-Resistant Cancers |
| » | Non-Surgical Breast Cancer Therapy Trial Underway in Japan |
| » | New Technique can Detect Breast Cancer by Analyzing Urine Samples |
| » | Low Radiation Scans Help Identify Cancer in Earliest Stages: Study |
| » | Researchers Say Timing of Cancer Radiation Therapy May Minimize Hair Loss |
| More Cancer News | |
|
Ask an Expert
